Schrödinger Launches Breakthrough Initiative to Advance Predictive Toxicology with Computational Tools
Schrödinger, Inc. has embarked on an initiative to enhance its computational platform for early predicting toxicology risk in drug...
Merck’s Keytruda and Padcev Combo Receives EU Recommendation for Unresectable Urothelial Carcinoma
The European Medicines Agency (EMA) has recommended approval of Merck’s KEYTRUDA and Padcev combination for the first-line treatment of...
LEO Pharma Receives Positive CHMP Opinion for Anzupgo® for Moderate to Severe Chronic Hand Eczema
LEO Pharma, a leading dermatology company, announced a positive opinion from the European Medicines Agency (EMA) for Anzupgo® (delgocitinib...
FDA on Real-World Data for Clinical Trial Regulatory Safety Studies
The 2024 DIA conference held a session on Harnessing Real-World Data to Generate Real-World Evidence for Clinical Trial Regulatory...
Investigational Lenacapavir for HIV Prevention: Remarkable New Results Unveiled
Gilead Sciences’ pivotal Phase 3 PURPOSE 1 trial has revealed compelling efficacy and safety results for lenacapavir, a novel...
Pfizer Uncovers Exciting Advance in Hemophilia A Gene Therapy
The AFFINE study evaluating giroctocogene fitelparvovec, a gene therapy for moderate to severe hemophilia A, has achieved significant results....
Psychedelics Make Mind-Blowing Progress in Poland
A groundbreaking alliance between Worldwide Clinical Trials (Worldwide), Centrum Badan Klinicznych PI-House, and the Polish Psychedelic Society (PTP) aims...
BeiGene Expands Presence in New Jersey with $800 Million Investment
BeiGene, a global oncology company, has established its flagship U.S. facility in Hopewell, New Jersey, aiming to bolster its...
ViiV Dovato: 2-Drug HIV-1 Regimen as Effective as 3-Drug Biktarvy
ViiV Healthcare’s PASO DOBLE study found that the 2-drug regimen Dovato (DTG/3TC) is as effective as the 3-drug regimen...
Azitra Strengthens Patent Portfolio with Latest Grants for Atopic Dermatitis
Azitra, Inc., a biopharmaceutical company specializing in dermatology, has secured a U.S. patent (No. 12,036,248) for its potential treatment...